Forecast

Buy	1
Hold	0
Sell	0

News Go to news feed

Haleon publishes latest figures on share capital and voting rights

Haleon has announced that as of July 31, 2025, the company has a total of 8,987,651,560 issued ordinary shares, of which 3,880,205 are held as treasury shares. The total number of shares with voting rights therefore amounts to 8,983,771,355. This information serves as the basis for calculations in accordance with the transparency requirements of the Financial Conduct Authority. » More on de.investing.com
Haleon appoints new members to committees

Haleon has appointed Bláthnaid Bergin to the audit and risk committee and Matt Shattock to the environmental and social sustainability committee. The appointments took immediate effect and were made in accordance with UK listing rules. The announcement was published by company secretary Amanda Mellor. » More on de.investing.com
Haleon stock delivers 12.16 percent return over three years

An investment of £1,000 in Haleon three years ago would be worth £1,121.64 today, representing an increase of 12.16 percent. The calculation does not account for stock splits or dividends. Haleon was first listed on the stock exchange in July 2022 and currently has a market capitalization of £31.87 billion. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Haleon PLC has already paid 0,0563€ in dividends. The last payout was in May.

Financials

In the last quarter, Haleon PLC had revenue of 3.19b€ and net profit of 469.43m€

(EUR)	Jun 2025	YoY
Revenue	+3.19b	-
Gross profit	+2.06b	-
Net profit	+469.43m	-
EBITDA	+811.32m	-

Fundamentals

Metric	Value
Market capitalization	+38.36b€
Number of shares	8.81b
52-week high/low	+4,94€ - +3,56€
Dividend yield	+1,88%
Dividends TTM	+0,0816€
Next dividend	+0,028€
Beta	0,24
P/E ratio	+20,58
PEG ratio	+3,50
P/B ratio	+2,03
P/S ratio	+2,95

Company profile

Haleon plc beschäftigt sich mit der Forschung und Entwicklung, der Herstellung und dem Verkauf verschiedener Produkte für die Gesundheitsvorsorge in Nordamerika, Europa, dem Nahen Osten, Afrika, Lateinamerika und dem asiatisch-pazifischen Raum. Das Unternehmen bietet therapeutische Produkte in den Bereichen Mundgesundheit, Schmerzlinderung, Atemwegsgesundheit, Verdauungsgesundheit und andere Produkte sowie Vitamine, Mineralien und Nahrungsergänzungsmittel an. Zu seinem Markenportfolio gehören Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax und Centrum. Das Unternehmen war früher unter dem Namen DRVW 2022 plc bekannt und änderte im Februar 2022 seinen Namen in Haleon plc. Haleon plc wurde im Jahr 2021 gegründet und hat seinen Hauptsitz in Brentford, Vereinigtes Königreich.

Name	Haleon PLC
CEO	Brian James McNamara
Headquarters	Weybridge, su United Kingdom
Website	haleon.com
Sector	Consumer Staples
Industry	Personal Care Products
IPO	07/18/2022
Employees	24.561